GlaxoSmithKline to Plead Guilty & Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant

DOJ press release 10-1205 (26 Oct 2010): SB Pharmco Puerto Rico (GSK) plea over adulterated drugs from the Cidra plant; $150 million criminal fine and forfeiture (incl. $10 million forfeiture); $600 million civil FCA settlement (federal $436,440,000, states up to $163,560,000) resolving one qui tam suit; whistleblower Cheryl Eckard receives about $96 million; HHS-OIG quote on nearly $2.3 billion pharmaceutical settlements in FY2010 (HHS-OIG figure, not an FCA total; not recorded); FCA recoveries since January 2009 (about $4.2 billion health care, over $5.4 billion total). Already in the data: 1 case and 1 event. Added: 2 cumulative FCA recovery observations.